| IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells R Salcedo, JK Stauffer, E Lincoln, TC Back, JA Hixon, C Hahn, ... The Journal of Immunology 173 (12), 7170-7182, 2004 | 223 | 2004 |
| Proteomic and genetic approaches identify Syk as an AML target CK Hahn, JE Berchuck, KN Ross, RM Kakoza, K Clauser, AC Schinzel, ... Cancer cell 16 (4), 281-294, 2009 | 189 | 2009 |
| Identification of racial inequities in access to specialized inpatient heart failure care at an academic medical center LA Eberly, A Richterman, AG Beckett, B Wispelwey, RH Marsh, ... Circulation: Heart Failure 12 (11), e006214, 2019 | 171 | 2019 |
| The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia V Banerji, SM Frumm, KN Ross, LS Li, AC Schinzel, CK Hahn, ... The Journal of clinical investigation 122 (3), 935-947, 2012 | 124 | 2012 |
| Molecular map of chronic lymphocytic leukemia and its impact on outcome BA Knisbacher, Z Lin, CK Hahn, F Nadeu, M Duran-Ferrer, KE Stevenson, ... Nature genetics 54 (11), 1664-1674, 2022 | 114 | 2022 |
| Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation CK Hahn, KN Ross, IM Warrington, R Mazitschek, CM Kanegai, ... Proceedings of the National Academy of Sciences 105 (28), 9751-9756, 2008 | 110 | 2008 |
| Eukaryotic initiation factor 2α phosphorylation mediates fetal hemoglobin induction through a post-transcriptional mechanism CK Hahn, CH Lowrey Blood, The Journal of the American Society of Hematology 122 (4), 477-485, 2013 | 46 | 2013 |
| Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA CK Hahn, CH Lowrey Blood, The Journal of the American Society of Hematology 124 (17), 2730-2734, 2014 | 42 | 2014 |
| High-throughput gene expression profiling of memory differentiation in primary human T cells WN Haining, J Angelosanto, K Brosnahan, K Ross, C Hahn, K Russell, ... BMC immunology 9, 1-11, 2008 | 34 | 2008 |
| A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer KH Dragnev, JD Whyman, CK Hahn, PE Kebbekus, SF Kokko, SM Bhatt, ... Journal of Thoracic Disease 10 (9), 5531, 2018 | 7 | 2018 |
| IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia C Syrykh, B Pons-Brun, N Russiñol, H Playa-Albinyana, T Baumann, ... Blood Advances 7 (23), 7384-7391, 2023 | 4 | 2023 |
| Genetically informed therapy for lymphoma: the discomfiting benefit of lumping splits CK Hahn, AC Palmer, DM Weinstock Cancer Cell 41 (10), 1696-1698, 2023 | | 2023 |
